Cambridge Cancer Genomics YC 지원서

Summer 2017Inactive

Cambridge Cancer Genomics은(는) Summer 2017 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2017
산업: HealthcareDiagnostics
팀 규모: 25
상태: Inactive
출시됨: 2017

창업자

John CassidyFounder/CEO
Nirmesh PatelFounder/Chief Scientific Officer
Evaline TsaiFounder/CPO

Cambridge Cancer Genomics의 사업 내용

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to

Cambridge Cancer Genomics의 YC 지원서, 재구성됨

Y Combinator 지원

Cambridge Cancer Genomics, Summer 2017 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Cambridge Cancer Genomics

Describe what your company does in 50 characters or less.

Personalized cancer treatment planning software

What is your company going to make? Please describe your product and what it does or will do.

We build software that helps oncologists interpret clinical and genomic data to pick the right drug for each cancer patient. Our platform analyzes patient biomarkers and treatment responses to guide precision oncology decisions.

Where do you live now, and where would the company be based after YC?

We currently live and work in Cambridge, England, United Kingdom, and the company remains based there.

Explain your decision regarding location.

Cambridge has the scientific and clinical expertise in genomics and oncology we need. Being close to hospitals and research centers allows faster collaboration and product validation.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Cambridge Cancer Genomics의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Cambridge Cancer Genomics의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Cambridge Cancer Genomics과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.